Search research articles
Contact Us
Filters
Showing results (491-500 of 520) with videos related to
Page
of 52
Sort By:
Journal of Medicinal Chemistry
|
June 11, 2015
Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor
Wylie S Palmer, Guillaume Poncet-Montange, Gang Liu, et al.
Epigenetics & Chromatin
|
September 24, 2015
Development of novel cellular histone-binding and chromatin-displacement assays for bromodomain drug discovery
Yanai Zhan, Maria Kost-Alimova, Xi Shi, et al.
Molecular Cancer Therapeutics
|
January 27, 2025
LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers
Lauren Catherine M Martires, Leanne G Ahronian, Charlotte B Pratt, et al.
Cancer Research
|
July 4, 2015
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies
Bhavatarini Vangamudi, Thomas A Paul, Parantu K Shah, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research
|
October 16, 2025
Tumor suppressor collateral damage screens reveal mRNA homeostasis protein HBS1L as a novel vulnerability in ch9p21 driven FOCAD deleted cancer
Hongxiang Zhang, Matthew R Tonini, Lauren Catherine M Martires, et al.
Ecology and Evolution
|
July 11, 2017
Bioclimatic transect networks: Powerful observatories of ecological change
Stefan Caddy-Retalic, Alan N Andersen, Michael J Aspinwall, et al.
Cancer Research
|
June 10, 2026
TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Anti-Tumor Immunity and Immunotherapy Efficacy
Alvin Ziying Lu, Brian B Haines, Wenhai Zhang, et al.
Molecular Cancer Therapeutics
|
October 13, 2022
Ubiquitinated PCNA Drives USP1 Synthetic Lethality in Cancer
Antoine Simoneau, Justin L Engel, Madhavi Bandi, et al.
Nature Communications
|
February 9, 2024
Amyloid-β aggregates activate peripheral monocytes in mild cognitive impairment
Kristian Juul-Madsen, Peter Parbo, Rola Ismail, et al.
Nature Biomedical Engineering
|
April 25, 2019
Publisher Correction: Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs
Matthew R Golder, Jenny Liu, Jannik N Andersen, et al.
Page
of 52
Search research articles
Search
Showing results (491-500 of 520) with videos related to
Sort By:
Page
of 52
Journal of Medicinal Chemistry
|
June 11, 2015
Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor
Wylie S Palmer, Guillaume Poncet-Montange, Gang Liu, et al.
Epigenetics & Chromatin
|
September 24, 2015
Development of novel cellular histone-binding and chromatin-displacement assays for bromodomain drug discovery
Yanai Zhan, Maria Kost-Alimova, Xi Shi, et al.
Molecular Cancer Therapeutics
|
January 27, 2025
LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers
Lauren Catherine M Martires, Leanne G Ahronian, Charlotte B Pratt, et al.
Cancer Research
|
July 4, 2015
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies
Bhavatarini Vangamudi, Thomas A Paul, Parantu K Shah, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research
|
October 16, 2025
Tumor suppressor collateral damage screens reveal mRNA homeostasis protein HBS1L as a novel vulnerability in ch9p21 driven FOCAD deleted cancer
Hongxiang Zhang, Matthew R Tonini, Lauren Catherine M Martires, et al.
Ecology and Evolution
|
July 11, 2017
Bioclimatic transect networks: Powerful observatories of ecological change
Stefan Caddy-Retalic, Alan N Andersen, Michael J Aspinwall, et al.
Cancer Research
|
June 10, 2026
TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Anti-Tumor Immunity and Immunotherapy Efficacy
Alvin Ziying Lu, Brian B Haines, Wenhai Zhang, et al.
Molecular Cancer Therapeutics
|
October 13, 2022
Ubiquitinated PCNA Drives USP1 Synthetic Lethality in Cancer
Antoine Simoneau, Justin L Engel, Madhavi Bandi, et al.
Nature Communications
|
February 9, 2024
Amyloid-β aggregates activate peripheral monocytes in mild cognitive impairment
Kristian Juul-Madsen, Peter Parbo, Rola Ismail, et al.
Nature Biomedical Engineering
|
April 25, 2019
Publisher Correction: Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs
Matthew R Golder, Jenny Liu, Jannik N Andersen, et al.
Page
of 52